We are live on ! Find out more
Balyasny Asset Management

Balyasny Asset Management Portfolio holdings

AUM $77.1B
1-Year Est. Return 42.89%
This Fund
S&P 500
This Quarter Est. Return
+3.26%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$5.96B
AUM Growth
Cap. Flow
+$5.98B
Cap. Flow %
100.34%
Top 10 Hldgs %
22.52%
Holding
529
New
528
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 11.67%
2 Energy 11%
3 Industrials 9.45%
4 Real Estate 8.03%
5 Healthcare 6.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QCOM icon
301
Qualcomm
QCOM
$168B
$4.78M 0.08%
+78,240
New +$4.99M
BEAT
302
DELISTED
BioTelemetry, Inc.
BEAT
$4.78M 0.08%
+810,230
New +$2.73M
CERN
303
CALL
DELISTED
Cerner Corp
CERN
$4.77M 0.08%
+198,400
New +$9.49M
CTSH icon
304
PUT
Cognizant
CTSH
$25.6B
$4.7M 0.08%
+150,000
New +$4.99M
STAG icon
305
STAG Industrial
STAG
$7.1B
$4.69M 0.08%
+234,922
New +$5.13M
PVTB
306
DELISTED
PrivateBancorp Inc
PVTB
$4.63M 0.08%
+218,116
New +$4.21M
WAT icon
307
Waters Corp
WAT
$39.2B
$4.59M 0.08%
+45,913
New +$4.4M
DXJ icon
308
WisdomTree Japan Hedged Equity Fund
DXJ
$7.35B
$4.56M 0.08%
+100,000
New +$4.67M
IBN icon
309
ICICI Bank
IBN
$109B
$4.56M 0.08%
+655,507
New +$5.19M
PCYC
310
DELISTED
PHARMACYCLICS INC
PCYC
$4.5M 0.08%
+56,563
New +$4.62M
BNNY
311
DELISTED
ANNIES INC COMMON STOCK (DE)
BNNY
$4.45M 0.07%
+104,137
New +$4.06M
LRCX icon
312
CALL
Lam Research
LRCX
$383B
$4.43M 0.07%
+1,000,000
New +$4.52M
AEGR
313
DELISTED
Aegerion Pharmaceuticals
AEGR
$4.43M 0.07%
+70,000
New +$3.72M
PLCE icon
314
Children's Place
PLCE
$58.9M
$4.42M 0.07%
+80,733
New +$4.07M
RLJ icon
315
RLJ Lodging Trust
RLJ
$1.81B
$4.42M 0.07%
+196,312
New +$4.5M
VRTX icon
316
Vertex Pharmaceuticals
VRTX
$123B
$4.4M 0.07%
+55,000
New +$4.05M
INCY icon
317
CALL
Incyte
INCY
$24B
$4.4M 0.07%
+200,000
New +$4.37M
DAR icon
318
Darling Ingredients
DAR
$9.62B
$4.39M 0.07%
+235,155
New +$4.35M
BWA icon
319
PUT
BorgWarner
BWA
$13.5B
$4.31M 0.07%
+113,600
New +$4M
CLDX icon
320
Celldex Therapeutics
CLDX
$3.26B
$4.29M 0.07%
+18,333
New +$3.61M
ESS icon
321
Essex Property Trust
ESS
$18.3B
$4.29M 0.07%
+26,996
New +$4.25M
NVS icon
322
Novartis
NVS
$293B
$4.28M 0.07%
+67,518
New +$4.39M
GLW icon
323
CALL
Corning
GLW
$135B
$4.27M 0.07%
+300,000
New +$4.36M
AGN
324
DELISTED
Allergan Inc
AGN
$4.26M 0.07%
+50,540
New +$5.24M
NUS icon
325
Nu Skin
NUS
$252M
$4.24M 0.07%
+69,385
New +$3.85M

Similar funds

Balyasny Asset Management's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for Balyasny Asset Management, which disclosed 529 positions worth $5.96B. Its ten largest holdings account for 23% of the portfolio.

Its largest position is Chicago Bridge & Iron Nv: 3,079,327 shares worth $184M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 12% of assets, followed by Energy and Industrials.

  • Balyasny Asset Management's largest Q2 2013 buy was Chicago Bridge & Iron Nv: 3,079,327 shares worth $184M.
  • Balyasny Asset Management's ten largest holdings make up 23% of its $5.96B portfolio in Q2 2013.
  • Balyasny Asset Management disclosed 529 positions in Q2 2013, its first 13F filing on record.

Based on Balyasny Asset Management's 13F filing for Q2 2013, filed 14 Aug 2013.